In 2012 our founder Jack started his PhD, tasked with investigating the role of an obscure neuropeptide in the architecture of sleep. Faced with hundreds of hours’ worth of recordings to manually score and analyze he had a breakdown and decided to pivot his project to create the missing technology that would have made his previous project fun instead of absolutely dreadful.
In 2015 Somnivore came alive, two years later Jack’s PhD was done and Somnivore became a peer-reviewed method. In 2019 Somnivore Pty Ltd was incorporated, opening the floodgates to fast, reliable and user-friendly sleep science data analytics.
Somnivore has expanded from sleep science to cater to many other areas of consciousness research, from psychedelic pharmacology, ecophysiology, and freediving research. Somnivore is as much a company as our adventure into the study of consciousness and what makes our life as humans, not just as scientists, worthwhile.
At Somnivore we hold a war chest of expertise in pharmaceutical development, data analytics, experimental design and regulatory approval strategies.
Somnivore is working with world-leading universities and industries across various fields of consciousness research including sleep science, psychedelic pharmacology, epilepsy, ecophysiology, and freediving research.